Measures | Hospital N.1 | Hospital N.2 | Hospital N.3 |
---|---|---|---|
1. Aspirin prescribed at discharge | 84.8% | 93.6% | 85.9% |
2. Beta-blocker prescribed at discharge | 81.7% | 72.2% | 65.6% |
3 Adult smoking cessation advice counseling. | 11.5% | 4.3% | 4.3% |
4. LDL cholesterol assessment | 15.9% | 13.9% | 0.3% |
5. Lipid lowering therapy at discharge | 81.7% | 74.2% | 71.8% |
6. Inpatient mortality | 7.6% | Â | Â |
7. Evaluation of left ventricular systolic (LVS) function (LVF Assessment) | 66.0% | 51.9% | 54.6% |
8. ACEI or ARB for left ventricular systolic dysfunction (LVSD) | 66.6% | 71.2% | 61.2% |
9. Adult smoking cessation advice counseling | 15.2% | 18.2% | 18.2% |
10. Thrombolytic therapy administered | 4.3% | 1.4% | 0.0% |
11. Discharged on cholesterol reducing medication | 21.3% | 41.4% | 21.5% |
12. Smoking cessation advice/counseling | 12.1% | Â | 80.0% |
13. Hip or Knee replacement Patients with Recommended Venous Thromboembolism (VTE) Prophylaxis Ordered | 92.9% | 0.0% | 12.0% |